Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects-Reference-Cited by-同舟云学术

Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects

Published:2017-09-22 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Sun Lu-Ning,Cao Yang,Li Yue-Qi,Fang Yun-Qian,Zhang Hong-Wen,Wang Mei-Feng,Xie Li-Jun,Chen Juan,Yang Zhi-Cheng,Bian Ming-Liang,Li Hao,Zhang Pei-Pei,Wei Ji-Fu,Meng Ling,Zhang Xue-Hui,Zhao Ping,Wang Yong-Qing

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. Conformational rearrangement of gastric H(+),K(+)-ATPase induced by an acid suppressant;Abe;Nat. Commun.,2011

2. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding;Aller;Science,2009

3. Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension vs. intact capsules;Amer;Clin. Ther.,2004

4. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents;Besancon;J. Biol. Chem.,1997

5. Study progress in pharmacokinetics of proton pump inhibitors;Chai;China Pharmacist.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton-Pump Inhibitors in Eosinophilic Esophagitis: A Review Focused on the Role of Pharmacogenetics;Pharmaceutics;2024-04-02

2. Relationship between CYP2C19 genotypes and proton pump inhibitorsʹs pharmacokinetics and pharmacodynamics: review;South Russian Journal of Therapeutic Practice;2024-03-29

3. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps;Pharmacogenomics and Personalized Medicine;2023-06

4. Lansoprazole-induced osteoporosis via the IP3R- and SOCE-mediated calcium signaling pathways;Molecular Medicine;2022-02-19

5. Amino acid derivatives of 2-Mercaptobenzimidazoles suppress cytokines at the site of inflammation and block gastric H⁺/K⁺ ATPase;PAK J PHARM SCI;2021